COLAPIETRO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 809
EU - Europa 515
AS - Asia 283
SA - Sud America 30
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.643
Nazione #
US - Stati Uniti d'America 807
IE - Irlanda 192
CN - Cina 115
SG - Singapore 112
DE - Germania 111
IT - Italia 59
SE - Svezia 46
TR - Turchia 37
UA - Ucraina 35
BR - Brasile 27
GB - Regno Unito 20
CZ - Repubblica Ceca 17
FI - Finlandia 10
VN - Vietnam 10
FR - Francia 9
BE - Belgio 8
IN - India 3
RU - Federazione Russa 3
BD - Bangladesh 2
EU - Europa 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
CR - Costa Rica 1
EC - Ecuador 1
HK - Hong Kong 1
IQ - Iraq 1
JP - Giappone 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.643
Città #
Chandler 194
Dublin 188
Jacksonville 133
Singapore 81
Santa Clara 48
New York 41
Boardman 37
Ann Arbor 32
Ashburn 32
Izmir 27
Munich 26
Nanjing 26
Grafing 24
Bremen 23
Lawrence 23
Princeton 23
Beijing 21
L'aquila 20
Wilmington 18
Brno 16
Dong Ket 10
Brussels 8
Nanchang 8
Woodbridge 8
Berlin 7
Falls Church 7
San Mateo 7
Tianjin 7
Dearborn 6
Los Angeles 6
L’Aquila 6
Changsha 5
Dallas 5
Helsinki 5
Kunming 5
Washington 5
Zhengzhou 5
Des Moines 4
Jinan 4
Norwalk 4
Rome 4
Seattle 4
São Paulo 4
Hebei 3
Milan 3
Shanghai 3
Tappahannock 3
Belo Horizonte 2
Caxias do Sul 2
Cedar Knolls 2
Frankfurt am Main 2
Fremont 2
Garland 2
Guangzhou 2
Hanover 2
Jiaxing 2
Menlo Park 2
Piombino Dese 2
Pune 2
Shenyang 2
Termoli 2
Verona 2
Amsterdam 1
Baghdad 1
Baoding 1
Brasília 1
Campos Sales 1
Carlentini 1
Casoria 1
Chelyabinsk 1
Contagem 1
Dhaka 1
Edinburgh 1
Escada 1
Fairfield 1
Fes 1
Guarujá 1
Guarulhos 1
Guayaquil 1
Hangzhou 1
Houston 1
Inhapim 1
Irkutsk 1
Jarinu 1
Jauru 1
Kuala Lumpur 1
Lagoa Santa 1
Linhares 1
Managua 1
Montevideo 1
Mountain View 1
Nanyang 1
Napoli 1
Ningbo 1
Orange 1
Osasco 1
Oslo 1
Pavia 1
Perth 1
Piên 1
Totale 1.247
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 130
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 118
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 108
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 101
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 96
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 87
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 82
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 78
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 76
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 71
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 69
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 63
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 63
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 63
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 62
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 61
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 57
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 55
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 53
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 49
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 49
The importance of tumor stem cells in glioblastoma resistance to therapy 46
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 45
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 23
Totale 1.705
Categoria #
all - tutte 7.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020118 0 0 0 0 0 20 32 6 22 17 0 21
2020/2021176 7 19 2 22 18 6 24 0 27 8 27 16
2021/2022176 8 0 21 8 5 31 5 5 14 32 10 37
2022/2023555 29 42 10 76 35 58 0 44 234 2 14 11
2023/2024169 19 5 8 2 19 61 1 8 0 4 9 33
2024/2025281 23 15 39 63 86 55 0 0 0 0 0 0
Totale 1.705